Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 791, Issue 1-2, 2003, Pages 227-233

  Sparidans, Rolf W ^a   Crommentuyn, Kristel M L ^b   Schellens, Jan H M ^a,c   Beijnen, Jos H ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Chloroacetaldehyde; Derivatization, LC; Tenofovir

Indexed keywords

FLUORESCENCE; IONS; PATIENT TREATMENT; PLASMAS;

REVERSED-PHASE LIQUID CHROMATOGRAPHY;

LIQUID CHROMATOGRAPHY;

ABACAVIR; ADEFOVIR; ALLOPURINOL; ANTIVIRUS AGENT; BUFFER; CHLOROACETALDEHYDE; DIDANOSINE; DOXORUBICIN; GRANISETRON; LAMIVUDINE; NUCLEOTIDE; TENOFOVIR; TENOFOVIR DISOPROXIL; TRICHLOROACETIC ACID; ZIDOVUDINE;

ACCURACY; ARTICLE; ASSAY; CASE REPORT; CHEMICAL ANALYSIS; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG ISOLATION; EXCITATION; FLUORESCENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ION PAIR CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SAMPLE; TEMPERATURE; VALIDATION PROCESS;

EID: 0038697799     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(03)00225-3     Document Type: Article

References (15)

1. De Clercq E. Biochim. Biophys. Acta. 1587:2002;258.
2. Robins B.L., Srinivas R.V., Kim C., Bischofsberger N., Fridland A. Antimicrob. Agents Chemother. 42:1998;612.
3. Barditch-Crovo P., Deeks S.G., Collier A., Safrin S., Coakley D.F., Miller M., Kearney B.P., Coleman R.L., Lamy P.D., Kahn J.O., McGowan I., Lietman P.S. Antimicrob. Agents Chemother. 45:2001;2733.
4. Gazzard B.G. Int. J. Clin. Pract. 55:2001;704.
5. Cundy K.C., Sueoka C., Lynch G.R., Griffin L., Lee W.A., Shaw J.-P. Antimicrob. Agents Chemother. 42:1998;687.
6. Deeks S.G., Barditch-Crovo P., Lietman P.S., Hwang F., Cundy K.C., Rooney J.F., Hellmann N.S., Saffrin S., Kahn J.O. Antimicrob. Agents Chemother. 42:1998;2380.
7. Van Gelder J., Deferme S., Annaert P., Naesens L., De Clercq E., Van den Mooter G., Kinget R., Augustijns P. Drug Metab. Dispos. 28:2000;1394.
8. Russell J.W., Marrero D., Whiterock V.J., Klunk L.J., Starrett J.E. J. Chromatogr. 572:1991;321.
9. Naesens L., Balzarini J., De Clercq E. Clin. Chem. 38:1992;480.
10. Sparidans R.W., Veldkamp A., Hoetelmans R.M.W., Beijnen J.H. J. Chromatogr. B. 736:1999;115.
11. Lynch T., Eisenberg G., Kernan M. Nucleosides Nucleotides Nucleic Acids. 20:2001;1415.
12. Aarnoutse R.E., Verweij-van Wissen C.P.W.G.M., Underberg W.J.M., Kleinnijenhuis J., Hekster Y.A., Burger D.M. J. Chromatogr. B. 764:2001;363.
13. Shah V.P., Midha K.K., Dighe S., McGliveray I.J., Skelly J.P., Jacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309.
14. Rosing H., Man W.Y., Doyle E., Bult A., Beijnen J.H. J. Liq. Chromatogr. Relat. Technol. 23:2000;329.
15. Center for Drug Evaluation and Research of the U.S. Department of Health and Human Services Food and Drug Administration, http://www.fda.gov/cder/guidance/4252fnl.htm, 2001.